Article

Single and 2-dose vaccinations with MVA-BN<sup>®</sup> induce durable B cell memory responses in healthy volunteers that are comparable to older generation replicating smallpox vaccines

2022-09-09

Abstract excerpt

While the MVA-BN vaccine has been proven protective against smallpox and monkeypox, the long-term immunological persistence or booster effect has not been described. In this set of clinical studies, participants who had never been immunized against smallpox were randomized to receive, 4 weeks apart: 2 placebo vaccinations (PBO group, N =181); 1 MVA-BN vaccination followed by placebo(1×MVA group, N =181); or 2 MVA-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c518de20-2e75-5076-bbae-5909c5d8bc15
DOI: 10.1101/2022.09.07.22279689

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Single and 2-dose vaccinations with MVA-BN<sup>®</sup> induce durable B cell memory responses in healthy volunteers that are comparable to older generation replicating smallpox vaccinesDOI 10.1101/2022.09.07.22279689Read

Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox VaccinationSemantic proximity Read

Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individualsSemantic proximity Read

Extended interval BNT162b2 vaccination enhances peak antibody generation in older peopleSemantic proximity Read

Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b studySemantic proximity Read

Immunological analysis of LC16m8 vaccine: preclinical and early clinical insights into mpoxSemantic proximity Read

Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines.Semantic proximity Read

The response to BTN62b2 booster doses demonstrates that serum antibodies do not predict the establishment of immune B-cell memory in common variable immune deficienciesSemantic proximity Read

BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotypeSemantic proximity Read

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.Semantic proximity Read

Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster doseSemantic proximity Read

IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cellsSemantic proximity Read

Plasmablast, memory B cell and T follicular helper cell responses after human papillomavirus vaccination: effect of dose number and ageSemantic proximity Read